108 studies found for:    Open Studies | "Exanthema"
Show Display Options
Rank Status Study
21 Recruiting "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy
Condition: Stroke
Interventions: Biological: rfVIIa;   Other: Standard saline solution
22 Recruiting The Value of Black Spots in Diagnosing Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy
Condition: Gastric Intestinal Metaplasia
Intervention: Procedure: CLE examination for upper gastrointestinal tract
23 Unknown  Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia
Condition: Preeclampsia
Intervention:
24 Recruiting Can a Spot Urine Replace or Improve 24 Hour Urine Collections in Kidney Stone Patients
Condition: Kidney Stones
Intervention:
25 Recruiting Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Adenocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Erlotinib;   Drug: Oxaliplatin;   Drug: Folinic Acid;   Drug: Irinotecan;   Drug: 5-FU
26 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
27 Unknown  Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Conditions: Dermatologic Complications;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: collagen/aloe vera/vitamin E/lidocaine topical hydrogel
28 Not yet recruiting Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
Condition: Preeclampsia
Intervention:
29 Recruiting A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Patients With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: erlotinib [Tarceva]
30 Recruiting A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 2
Condition: Early Caries Lesions
Interventions: Device: CPP-ACP (GC Tooth Mousse);   Device: CPP-ACP (GC MI Paste Plus);   Device: Fluoride (Elmex Medical Gel)
31 Recruiting A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1
Condition: Early Caries Lesions
Interventions: Device: CPP-ACP (GC Tooth Mousse);   Device: CPP-ACP (GC MI Paste Plus)
32 Not yet recruiting Efficacy of Handheld Acne Heat Device
Condition: Acne Vulgaris
Interventions: Device: Split face: handheld acne heat based device (Zeno Hot Spot) and no treatment;   Device: Split face: handheld acne heat based device, Zeno Hot Spot, and topical benzoyl peroxide 4%
33 Recruiting Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream
Condition: Medication Reaction
Intervention: Drug: Tretinoin
34 Recruiting A Study to Determine the Location of the Blind Spot and the Macula-disc Centre Distance on a Fundus Photograph
Condition: Generalized Visual Field Contraction or Constriction
Intervention:
35 Recruiting Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot
Condition: Healthy Volunteers
Intervention: Drug: Cocktail probe drugs
36 Unknown  Line Versus Spot Ablation in Persistent Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: linear anatomically oriented ablations;   Procedure: focal electrophysiological oriented ablations
37 Recruiting Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment
Condition: Beta-lactam Allergy
Intervention: Drug: Beta-lactam oral challenge
38 Recruiting Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.
Condition: Claudication
Interventions: Drug: Percutaneous transluminal angioplasty of femoropopliteal artery lesions with primary long;   Drug: short stenting for the primary outcome and use of cilostazol for 12 months for secondary outcome.
39 Recruiting Study of Procoagulation Markers in Stroke Patients
Conditions: Stroke;   Hyperglycemia;   Procoagulation Markers
Intervention: Other: Glycemic Control
40 Recruiting Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders
Condition: Hypertension, Pregnancy-Induced
Intervention: Other: Hypertensive disorder of pregnancy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years